KATHALENE KELLER RINEY: Open Payments
NPI 1457786642 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$94,151 in 351 payments from 34 companies in 2025. Trend: 2023 $128,563 · 2024 $73,636 · 2025 $94,151
Speaker / faculty: $79,513Travel & lodging: $7,400Food & beverage: $5,604Consulting: $1,340Education: $294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 149 | $79,053 |
| Phathom Pharmaceuticals, Inc. | 22 | $11,304 |
| AstraZeneca Pharmaceuticals LP | 11 | $406 |
| Janssen Biotech, Inc. | 16 | $402 |
| Corcept Therapeutics | 15 | $280 |
| Novo Nordisk Inc | 12 | $274 |
| Otsuka America Pharmaceutical, Inc. | 12 | $272 |
| E.R. Squibb & Sons, L.L.C. | 15 | $237 |
| Axsome Therapeutics, Inc. | 14 | $185 |
| PFIZER INC. | 12 | $171 |
Products named: VRAYLAR, VOQUEZNA, TREMFYA, REXULTI, AIRSUPRA, Korlym, QULIPTA, Sotyktu.
Industry payments across IN — which companies pay providers there.
